GGrantIndex
Sort

78,016 grants matching breast cancer

Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research

$939,361
Xihong Lin · Harvard School Of Public Health · R35 · FY2022 · CA

BIOMEDICAL (MANAGEMENT/SUPPORT)

$939,308
Subha Madhavan · Georgetown University · N02 · FY2009 · CA

Continued studies of environment impact on puberty

$938,988
Frank M Biro · Cincinnati Childrens Hosp Med Ctr · U01 · FY2012 · ES

Ultrasound Imaging of Breast by Use of a Hemispheric Array and Inverse Scattering

$938,709
Robert C Waag · University Of Rochester · R01 · FY2009 · EB

Illinois Oncology Research Association CCOP

$938,655
John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2008 · CA

Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer

$938,597
Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2022 · CA

CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI

$937,969
University Of California Los Angeles · N01 · FY2000 · WH

Biochemical Markers in the Nurses? Health Study Cohort

$937,466
Susan E. Hankinson · University Of Massachusetts Amherst · U01 · FY2011 · CA

Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy

$937,462
Irving Lerner Weissman · Stanford University · R35 · FY2020 · CA

Cancer and Context

$937,460
Ian G Macara · Vanderbilt University · R35 · FY2018 · CA

Breast Cancer Risk and Molecular Change After Chernobyl

$937,367
Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Impact of Hearing Loss and Tinnitus in Cancer Survivors

$937,214
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2019 · CA

Genetics and Epigenetics of Cancer

$937,159
Maxwell Lee · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

A prospective, multi-center pivotal study of the LUM Imaging System for real-time, in vivo margin assessment in breast conserving surgery

$937,091
W. David Lee · Lumicell, Inc. · R44 · FY2017 · CA

Preclinical development of TIMP-2 as a biologic therapy for cancer

$936,906
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

A recombinant matrix to improve autologous tissue grafts

$936,817
Stefan Roberts · Insoma Bio, Inc. · R44 · FY2022 · CA

Clinical production of viral vectors for cancer gene therapy

$936,788
Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

EXERCISE EFFECT ON SEX HORMONES IN POSTMENOPAUSAL WOMEN

$936,515
Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA

Minority Based Community Clinical Oncology Program

$936,500
David J Peace · University Of Illinois At Chicago · U10 · FY2008 · CA

Ann Arbor regional CCOP

$936,494
Saint Joseph Mercy Health System · U10 · FY2002 · CA

Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers

$936,457
Laura J Esserman · University Of California, San Francisco · U01 · FY2016 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$936,361
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2023 · CA

Mouse Models for Human Cancer

$936,359
Raju S Kucherlapati · Brigham And Women'S Hospital · U01 · FY2007 · CA

Integrated, Individualized, Intelligent Prescribing (I3P)

$936,331
Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2017 · HG

MOTILITY AND INVASION

$936,321
John S Condeelis · Albert Einstein College Of Medicine · P01 · FY2018 · CA